Valuation Kobayashi Pharmaceutical Co., Ltd.

Stocks

4967

JP3301100008

Personal Products

Delayed Japan Exchange 07:24:12 12/08/2026 +03 5-day change 1st Jan Change
5,560.00 JPY -1.01% Intraday chart for Kobayashi Pharmaceutical Co., Ltd. +0.98% +2.43%

Company Valuation: Kobayashi Pharmaceutical Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 704,427 650,295 503,841 463,131 403,511 417,560 - -
Change - -7.68% -22.52% -8.08% -12.87% 3.48% - -
Enterprise Value (EV) 1 596,011 546,554 424,992 398,232 333,575 359,699 347,761 341,889
Change - -8.3% -22.24% -6.3% -16.24% 7.83% -3.32% -1.69%
P/E 35.8x 34.8x 25.3x 46x 110x 41x 30.8x 24.9x
PBR 3.59x 3.47x 2.47x 2.18x 1.92x 1.98x 1.93x 1.87x
PEG - 12.08x 7.7x -0.9x -1.7x 0x 0.9x 1.1x
Capitalization / Revenue 4.54x 3.91x 2.9x 2.8x 2.43x 2.42x 2.32x 2.24x
EV / Revenue 3.84x 3.29x 2.45x 2.4x 2.01x 2.08x 1.93x 1.83x
EV / EBITDA 19.3x 17.1x 13.3x 12.1x 14.1x 16.2x 12.9x 10.9x
EV / EBIT 22.9x 20.5x 16.5x 16x 22.4x 27.4x 19.9x 15.9x
EV / FCF 31.8x 31.1x -350x -29.2x 68.5x 24.7x 22.7x 19.9x
FCF Yield 3.15% 3.22% -0.29% -3.42% 1.46% 4.04% 4.4% 5.04%
Dividend per Share 2 83 90 101 102 104 106 109.5 114.3
Rate of return 0.92% 1% 1.49% 1.64% 1.92% 1.89% 1.95% 2.03%
EPS 2 252.4 259.6 268.2 135.4 49.19 137 182.5 225.4
Distribution rate 32.9% 34.7% 37.7% 75.3% 211% 77.4% 60% 50.7%
Net sales 1 155,252 166,258 173,455 165,600 165,742 172,560 179,820 186,639
EBITDA 1 30,900 32,027 31,837 32,800 23,600 22,180 27,030 31,262
EBIT 1 26,065 26,669 25,780 24,860 14,923 13,125 17,494 21,464
Net income 1 19,715 20,022 20,338 10,067 3,656 10,255 13,674 16,493
Net Debt 1 -108,416 -103,741 -78,849 -64,899 -69,936 -57,862 -69,799 -75,671
Reference price 2 9,040.00 9,030.00 6,790.00 6,230.00 5,428.00 5,617.00 5,617.00 5,617.00
Nbr of stocks (in thousands) 77,923 72,015 74,203 74,339 74,339 74,339 - -
Announcement Date 2/4/22 A 2/14/23 A 2/9/24 A 2/10/25 A 2/10/26 A - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
41.01x2.08x16.22x1.89% 2.62B
21.21x4.11x14.98x3.01% 338B
17.88x2.72x12.02x3.52% 134B
25.33x3.78x15.9x2.28% 73.59B
43.29x6.98x30.27x2.13% 50.87B
20.01x2.8x11.74x4.45% 36.59B
84.32x2.49x14.98x1.61% 31.76B
24.42x1.79x11.39x2.09% 21.23B
16.21x1.56x8.86x3.26% 19.81B
21.02x1.36x8.68x1.24% 20.08B
Average 31.47x 2.97x 14.50x 2.55% 72.81B
Weighted average by Cap. 25.27x 3.67x 14.99x 2.91%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 4967 Stock
  4. Valuation Kobayashi Pharmaceutical Co., Ltd.